Kaleido Biosciences, Inc.

Home » Kaleido Biosciences, Inc.

IPO

Kaleido Biosciences, Inc.

We are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.

Symbol

KLDO

Price Range
$20.00 - $22.00

Final Shares
4,761,000

Effective Date
February 28, 2019

Underwriters
GOLDMAN SACHS & CO. LLC

To view the prospectus for Kaleido Biosciences, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253